Children with leukaemia to receive CAR-T therapy on the NHS

Naturally, we hope no family will ever need to use their child's stem cells. But sometimes they do. That's why we make sure every collection in our care is treated with exceptional attention to detail. We want to give families the best possible chance of a healthy future.
Kate_Sneddon_CEO_Biovault
Kate Sneddon
Biovault CEO & Microbiologist
Fantastic news today as children with leukaemia will be able to access CAR-T therapy on the NHS. The CAR-T cells in this pilot have been derived from peripheral blood. Groups are working on the same process using CAR-T cells from umbilical cord blood, a non-invasive source of therapeutic cells. Biovault’s Shaun Mansfield, a stem cell scientist specialising in umbilical cord cells says: “We’re delighted at this step forward in cell-based therapies.”

Let's get you started

Family

Cord blood processing and storage for families. Choose a 10 or 25 storage period and reduced fees for twins.

Family Plus

Cord blood and tissue storage for families wishing to store stem cell-rich umbilical tissue as well as cord blood.